Lyka Labs has informed the exchanges that Lyka Healthcare Ltd, a wholly owned subsidiary of the company, has launched two domestic marketing divisions - Enspan and Cerabelle. Enspan would be marketing critical and anesthesia range of products while Cerabelle would go for dermatology and cosmetology range of products. The above products would also be offered internationally in the 46 countries in which Lyka has its presence. Shares of Lyka Labs gained 2.34 per cent at ₹85 on the NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.